Detalhe da pesquisa
1.
Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study.
Breast Cancer Res Treat
; 205(2): 349-358, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244167
2.
Meta-Analysis of Circulating Tumor Cell PD-L1 Expression and the Association with Clinical Outcomes in Non-Small Cell Lung Cancer.
Clin Chem
; 70(1): 234-249, 2024 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175603
3.
A Rapid, Shallow Whole Genome Sequencing Workflow Applicable to Limiting Amounts of Cell-Free DNA.
Clin Chem
; 69(5): 510-518, 2023 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747279
4.
CDK7 inhibitors as anticancer drugs.
Cancer Metastasis Rev
; 39(3): 805-823, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32385714
5.
FOXA1 is a determinant of drug resistance in breast cancer cells.
Breast Cancer Res Treat
; 186(2): 317-326, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417085
6.
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients.
Breast Cancer Res Treat
; 188(2): 465-476, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34097174
7.
Plasma cell-free DNA (cfDNA) as a predictive and prognostic marker in patients with metastatic breast cancer.
Breast Cancer Res
; 21(1): 149, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31856868
8.
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIES.
Breast Cancer Res Treat
; 175(1): 149-163, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30680659
9.
Correction: Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study.
Breast Cancer Res Treat
; 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704774
10.
p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
Nucleic Acids Res
; 45(19): 11056-11069, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28977491
11.
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.
Breast Cancer Res Treat
; 171(1): 65-74, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29766362
12.
IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer.
Breast Cancer Res Treat
; 166(2): 527-539, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28795252
13.
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
Breast Cancer Res Treat
; 163(3): 461-474, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341962
14.
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.
Breast Cancer Res Treat
; 165(2): 343-353, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28612226
15.
Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer.
Clin Chem
; 63(2): 532-541, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27940449
16.
Stratified, precision or personalised medicine? Cancer services in the 'real world' of a London hospital.
Sociol Health Illn
; 39(1): 143-158, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27460935
17.
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
Gastroenterology
; 146(1): 268-77.e18, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24120476
18.
Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.
Genome Res
; 22(2): 220-31, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21990379
19.
Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer.
Clin Chem
; 61(7): 974-82, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25979954
20.
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts.
Nucleic Acids Res
; 41(10): 5400-12, 2013 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23580553